Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder.
Laura Simões de Oliveira, Heather E O'Leary, Sarfaraz Nawaz and 16 others
PMID 38877552WHAT IT FOUND
In rats lacking the CDKL5 protein, hippocampal plasticity was enhanced and spine density increased, but receptor function remained normal.
The mechanisms driving these changes are unclear and differ from mouse models, so no direct clinical application exists for therapists yet.
Key findings
01Hippocampal long-term potentiation was enhanced in juvenile rats lacking CDKL5 compared to wild-type controls.
02NMDA and AMPA receptor function, including subunit composition and developmental trajectories, remained normal in the absence of CDKL5.
03Spine density was increased in the basal dendrites of hippocampal neurons, while overall dendritic complexity and cellular excitability were unaffected.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an animal study using rats, not humans. The study used male rats with a complete loss of the protein, whereas most human patients are females with one mutated copy and one normal copy. The rats did not show spontaneous seizures, which are a core feature of the human disorder. The mechanisms causing the observed changes in plasticity and spine density remain unknown. Findings in rats differed from previous findings in mice, suggesting species-specific effects.
Declared interests
Funding was provided by NIH/NIMH, the International Foundation for CDKL5 Research, the Ponzio Family Research Chair, the LouLou Foundation, the Wellcome Trust, and the Simons Foundation Autism Research Initiative.
The easy way to misread this
Do not interpret these cellular changes as evidence of a treatment target or a direct cause of human symptoms. The study identifies biological differences in a rat model but does not explain how these relate to the clinical features of CDKL5 deficiency disorder, nor does it test any interventions.